InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
T+90 hit rate
67%
T+90 mean return
+20.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Lizzul Paul F., Directeur Médical. Insider active across 1 company, notably Anaptysbio, INC. In total, 20 reports have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €401k. Activity tracked since 15 November 2021. The latest transaction was disclosed on 5 January 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lizzul Paul F.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
8,525 sharesCommon StockSEC:0001711462-26-000006:0
6,145 sharesCommon StockSEC:0001711462-26-000004:0
10,555 sharesCommon StockSEC:0001711462-26-000002:0
4,219 shares@ US$43.2624.3% of flowCommon StockSEC:0001711462-26-000002:1
1,500 shares@ US$18.503.7% of flowCommon StockSEC:0001711462-25-000003:0
1,500 shares@ US$50.0010.0% of flowCommon StockSEC:0001711462-25-000003:1
10,555 sharesCommon StockSEC:0001415889-25-001046:0
4,336 shares@ US$14.609.6% of flowCommon StockSEC:0001415889-25-001046:1
6,145 sharesCommon StockSEC:0001415889-25-001046:2
2,261 shares@ US$15.305.2% of flowCommon StockSEC:0001415889-25-001046:3
1,500 shares@ US$18.503.9% of flowCommon StockSEC:0001415889-24-023900:0
1,500 shares@ US$38.678.1% of flowCommon StockSEC:0001415889-24-023900:1
6,000 sharesCommon StockSEC:0001415889-24-023550:0
2,220 shares@ US$38.9312.1% of flowCommon StockSEC:0001415889-24-023550:1
2,000 shares@ US$18.505.2% of flowCommon StockSEC:0001415889-24-021452:0
1,500 shares@ US$18.504.0% of flowCommon StockSEC:0001415889-24-019829:0
6,145 shares0Common StockSEC:0001209191-24-001280:0
2,554 shares@ US$21.817.9% of flowCommon StockSEC:0001209191-24-001280:1
6,000 sharesCommon StockSEC:0001209191-23-049810:0
964 shares@ US$22.030.0010% mcap50.0% of flowCommon StockSEC:0001209191-21-065178:0
20 of 20 declarations
About Lizzul Paul F.
Paul F. Lizzul is Chief Medical Officer at ANAPTYSBIO, INC. He is responsible for the company's medical and clinical initiatives, contributing to innovation in the biotechnology field.
